Experienced independent investor group, since late 1990, focused on public biotech companies in Nordic markets. We let our performance speak for itself.
Malmö and London
Joined October 2019
- Tweets1K
- Following80
- Followers4K
- Likes121
The Biotech Analyst Group retweeted
CombiGene and Neurochase begin work to optimize the administration of CG01
combigene.com/en/news-and-re…
The Biotech Analyst Group retweeted
Nya data från 2cureX IndiTreat på ASCO
#BioStockSwe #lifesciences @2cureX biostock.se/2021/05/nya-data…
The Biotech Analyst Group retweeted
CEO Jan Nilsson is one of the speakers as “The Future of Swedish and Danish Life Science” celebrates its 10th anniversary
He will present his experiences within gene therapy under the heading Gene Therapy, an important tool for precision medicine.
swedishdanishlifescience.se/
The Biotech Analyst Group retweeted
Biovica invites to Capital Market Day on June 9th, 14:00 to 16:00.
loom.ly/26kKcGI
#Biovica #DiviTum #treatmentswithgreaterconfidence #breastcancer
The Biotech Analyst Group retweeted
#AegirBio
Viraspec - Rapid Covid-19 Testing
Reklam tillgängligt på AegirBios nya YouTube kanal!
youtube.com/watch?v=r0cptUF2…
#finanstwitter
The Biotech Analyst Group retweeted
Tomorrow, we publish our Q1 Interim Report and will be hosting a live audiocast with Q&A at 10:00 am CET. Scandion Oncology will be represented by Bo Rode Hansen, President & CEO and Carit Jacques Andersen, CFO.
Join here: financialhearings.com/event/…
#Scandion #SCOL #Aktier #Börs
The Biotech Analyst Group retweeted
"A unique technology, together with a dedicated team, Management, Board and owners means 2021 will be an exciting year for Inhalation Sciences" CEO. ISAB's Annual Report 2020 is out now. inhalation.se/investors/fina… #inhalation #aerosols #respiratoryresearch #ContractResearch
The Biotech Analyst Group retweeted
Biostock summerar CombiGenes framsteg på vägen mot första studie i människa
biostock.se/2021/05/combigen…
The Biotech Analyst Group retweeted
Today our President & CEO, Bo Rode Hansen will give a company presentation including Q&A at 10 am
Sign up for Nordnet Live x Biotekvirksomheder here: events.nordnet.dk/nordnet-ev…
#Scandion #SCOL #Aktier #Börs
The Biotech Analyst Group retweeted
2cureX låser upp kraften i precisionsonkologin
#BioStockSwe #lifesciences @2cureX biostock.se/2021/05/2curex-l…
The Biotech Analyst Group retweeted
New preclinical data for #COVID19 vaccine confirm potential for broad protection against SARS-CoV2 variants bavarian-nordic.com/investor…
The Biotech Analyst Group retweeted
Understanding #LongCovid through genomics, immunology and virology @metricausa @naturemethods for highlighting our ongoing work nature.com/articles/s41592-0…
The Biotech Analyst Group retweeted
Håller med, postade ett inlägg där jag jämförde AegirBios kommande värdestegring med Enzymaticas (Efter lansering av ColdZyme). Med en intäkt på 111milj 2020 värderades dem 3,6Mdr kr. AegirBio värderas halva med ett potential till att dra in 10-20ggr mer under 2021! :)
The Biotech Analyst Group retweeted
2cureX en blivandenyckelspelare inom precisionscancerbehandling
#BioStockSwe #lifesciences @2cureX biostock.se/2021/04/2curex-e…
The Biotech Analyst Group retweeted
ExpreS2ion appoints new Vice President, Business Development #VPBD #ProteinsForLife news.cision.com/expres2ion-b…
The Biotech Analyst Group retweeted
It's #WorldMalariaDay - An effective #vaccine is a priority to #endmalaria. @ExpreS2ionB research contributes to malaria vaccine development, making malaria parasite proteins with correct folding and yields for further R&D. Eg. ow.ly/xwwj50EvSB2.
The Biotech Analyst Group retweeted
Scandion Oncologys COO om viktiga kommande kliniska milstolpar
#BioStockSwe #lifesciences @Scandion biostock.se/2021/04/scandion…
The Biotech Analyst Group retweeted
Publication of clinical Phase I/IIa data in the RH5 blood-stage malaria vaccine #malariaresearch #malaria #biotech #RH5 #ProteinsForLife #ExpreS2 #VaccinesWork news.cision.com/expres2ion-b…
The Biotech Analyst Group retweeted
Interim safety update on COUGH-1, the COVID-19 clinical phase I/II study for the ABNCoV2 vaccine #COVID19research #COVID19 #vaccineswork #clinicalsafety #proteinsforlife #ExpreS2 news.cision.com/expres2ion-b…